Clinical Trial Details
Trial ID: | L1087 |
Source ID: | NCT02827435 |
Associated Drug: | Rocuronium Bromide |
Title: | Acute Pharmacokinetic-pharmacodynamic Change of Rocuronium After Reperfusion of Renal Graft |
Acronym: | |
Status: | RECRUITING |
Study Results: | NO |
Results: | |
Conditions: | End Stage Renal Disease|Transplantation |
Interventions: | DRUG: Rocuronium bromide |
Outcome Measures: | Primary: rocuronium plasma concentration (mcg/ml), PKPD modeling from measuring plasma rocuronium concentration and excreted urine rocuronium amount, 0, 1, 3, 5, 10, 30, 60, 90, 120 minutes after rocuronium second bolus injection|acceleromyography data (TOF ratio %), Muscle relaxation level (TOF, T1) will be evaluated via acceleromyography. The pharmacodynamic modeling with NONMEM throughout the kidney transplantation., intraoperative | |
Sponsor/Collaborators: | Sponsor: Seoul National University Hospital |
Gender: | ALL |
Age: | ADULT |
Phases: | |
Enrollment: | 12 |
Study Type: | INTERVENTIONAL |
Study Designs: | Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE |
Start Date: | 2016-07-01 |
Completion Date: | 2024-12-31 |
Results First Posted: | |
Last Update Posted: | 2023-12-01 |
Locations: | Seoul National University Hospital, Seoul, Korea, Republic of |
URL: | https://clinicaltrials.gov/show/NCT02827435 |

Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
---|